Compounds > trimethoprim--sulfamethoxazole-drug-combination

trimethoprim--sulfamethoxazole-drug-combination and Deafness

trimethoprim--sulfamethoxazole-drug-combination has been researched along with Deafness* in 2 studies

Other Studies

2 other study(ies) available for trimethoprim--sulfamethoxazole-drug-combination and Deafness

ArticleYear
Irreversible ototoxicity associated with zalcitabine.
    International journal of STD & AIDS, 1997, Volume: 8, Issue:3

    Topics: Adult; Anti-HIV Agents; Anti-Infective Agents; Deafness; Drug Therapy, Combination; Female; HIV Infections; Humans; Trimethoprim, Sulfamethoxazole Drug Combination; Zalcitabine

1997
Chronic neurobrucellosis due to Brucella melitensis.
    Scandinavian journal of infectious diseases, 1990, Volume: 22, Issue:2

    A 20-year-old male Turkish immigrant to Norway suffering from severe chronic neurobrucellosis with spastic paraplegia and deafness is presented. The diagnosis was established by isolation of Brucella melitensis from cerebrospinal fluid (CSF) culture. Brucella antibody agglutination titers were high in serum and CSF. In spite of intensive, prolonged treatment with a combination of trimethoprim-sulfamethoxazole (TPM-SMZ), rifampicin and doxycycline, the course of the illness was characterized by relapses and severe neurological defects.

    Topics: Adult; Agglutination; Brucellosis; Deafness; Humans; Male; Paraplegia; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Turkey

1990